152 related articles for article (PubMed ID: 30693059)
1. Inhibition of NF-kappaB transcriptional activity enhances fucoxanthinol-induced apoptosis in colorectal cancer cells.
Tamura S; Narita T; Fujii G; Miyamoto S; Hamoya T; Kurokawa Y; Takahashi M; Miki K; Matsuzawa Y; Komiya M; Terasaki M; Yano T; Mutoh M
Genes Environ; 2019; 41():1. PubMed ID: 30693059
[TBL] [Abstract][Full Text] [Related]
2. Anti-neoplastic effects of fucoxanthin and its deacetylated product, fucoxanthinol, on Burkitt's and Hodgkin's lymphoma cells.
Tafuku S; Ishikawa C; Yasumoto T; Mori N
Oncol Rep; 2012 Oct; 28(4):1512-8. PubMed ID: 22859062
[TBL] [Abstract][Full Text] [Related]
3. Effects of CLIC4 on Fucoxanthinol-Induced Apoptosis in Human Colorectal Cancer Cells.
Yokoyama R; Kojima H; Takai R; Ohta T; Maeda H; Miyashita K; Mutoh M; Terasaki M
Nutr Cancer; 2021; 73(5):889-898. PubMed ID: 33703973
[TBL] [Abstract][Full Text] [Related]
4. Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas.
Yamamoto K; Ishikawa C; Katano H; Yasumoto T; Mori N
Cancer Lett; 2011 Jan; 300(2):225-34. PubMed ID: 21078541
[TBL] [Abstract][Full Text] [Related]
5. Glycine and succinic acid are effective indicators of the suppression of epithelial-mesenchymal transition by fucoxanthinol in colorectal cancer stem-like cells.
Terasaki M; Mima M; Kudoh S; Endo T; Maeda H; Hamada J; Osada K; Miyashita K; Mutoh M
Oncol Rep; 2018 Jul; 40(1):414-424. PubMed ID: 29693702
[TBL] [Abstract][Full Text] [Related]
6. Requirement of CLIC4 Expression in Human Colorectal Cancer Cells for Sensitivity to Growth Inhibition by Fucoxanthinol.
Yokoyama R; Kushibiki A; Yamada S; Kubota A; Kojima H; Ohta T; Hamada J; Maeda H; Mutoh M; Terasaki M
Cancer Genomics Proteomics; 2022; 19(4):428-444. PubMed ID: 35732323
[TBL] [Abstract][Full Text] [Related]
7. A Marine Carotenoid of Fucoxanthinol Accelerates the Growth of Human Pancreatic Cancer PANC-1 Cells.
Terasaki M; Takahashi S; Nishimura R; Kubota A; Kojima H; Ohta T; Hamada J; Kuramitsu Y; Maeda H; Miyashita K; Takahashi M; Mutoh M
Nutr Cancer; 2022; 74(1):357-371. PubMed ID: 33590779
[TBL] [Abstract][Full Text] [Related]
8. Fucoxanthin and Colorectal Cancer Prevention.
Terasaki M; Kubota A; Kojima H; Maeda H; Miyashita K; Kawagoe C; Mutoh M; Tanaka T
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069132
[TBL] [Abstract][Full Text] [Related]
9. A Fucoxanthinol Induces Apoptosis in a Pancreatic Intraepithelial Neoplasia Cell.
Terasaki M; Inoue T; Murase W; Kubota A; Kojima H; Kojoma M; Ohta T; Maeda H; Miyashita K; Mutoh M; Takahashi M
Cancer Genomics Proteomics; 2021; 18(2):133-146. PubMed ID: 33608310
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects between fucoxanthinol and its precursor fucoxanthin on viability and apoptosis of breast cancer cell lines MCF-7 and MDA-MB-231.
Rwigemera A; Mamelona J; Martin LJ
Anticancer Res; 2015 Jan; 35(1):207-19. PubMed ID: 25550553
[TBL] [Abstract][Full Text] [Related]
11. Dual Biological Functions of a Cytoprotective Effect and Apoptosis Induction by Bioavailable Marine Carotenoid Fucoxanthinol through Modulation of the Nrf2 Activation in RAW264.7 Macrophage Cells.
Taira J; Sonamoto M; Uehara M
Mar Drugs; 2017 Oct; 15(10):. PubMed ID: 28984834
[TBL] [Abstract][Full Text] [Related]
12. Fucoxanthinol, Metabolite of Fucoxanthin, Improves Obesity-Induced Inflammation in Adipocyte Cells.
Maeda H; Kanno S; Kodate M; Hosokawa M; Miyashita K
Mar Drugs; 2015 Aug; 13(8):4799-813. PubMed ID: 26248075
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of fucoxanthinol on the viability of human breast cancer cell lines MCF-7 and MDA-MB-231 are correlated with modulation of the NF-kappaB pathway.
Rwigemera A; Mamelona J; Martin LJ
Cell Biol Toxicol; 2014 Jun; 30(3):157-67. PubMed ID: 24760606
[TBL] [Abstract][Full Text] [Related]
14. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
Shukla S; Gupta S
Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT
Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anti-colorectal cancer effects of carfilzomib combined with CPT-11 via downregulation of nuclear factor-κB in vitro and in vivo.
Tang W; Su G; Li J; Liao J; Chen S; Huang C; Liu F; Chen Q; Ye Y
Int J Oncol; 2014 Sep; 45(3):995-1010. PubMed ID: 24968890
[TBL] [Abstract][Full Text] [Related]
17. Fucoxanthin Inhibits Development of Sigmoid Colorectal Cancer in a PDX Model With Alterations of Growth, Adhesion, and Cell Cycle Signals.
Terasaki M; Tsuruoka K; Tanaka T; Maeda H; Shibata M; Miyashita K; Kanemitsu Y; Sekine S; Takahashi M; Yagishita S; Hamada A
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):686-705. PubMed ID: 38035706
[TBL] [Abstract][Full Text] [Related]
18. Glycine Is a Predictor for a Suppressive Effect of Fucoxanthinol on Colonosphere Formation Under Hypoxia.
Terasaki M; Ogawa Y; Endo T; Maeda H; Hamada J; Osada K; Miyashita K; Mutoh M
Anticancer Res; 2018 Apr; 38(4):2169-2179. PubMed ID: 29599336
[TBL] [Abstract][Full Text] [Related]
19. Effect of Fucoxanthinol on Pancreatic Ductal Adenocarcinoma Cells from an
Terasaki M; Nishizaka Y; Murase W; Kubota A; Kojima H; Kojoma M; Tanaka T; Maeda H; Miyashita K; Mutoh M; Takahashi M
Cancer Genomics Proteomics; 2021; 18(3 Suppl):407-423. PubMed ID: 33994364
[TBL] [Abstract][Full Text] [Related]
20. Efficient Preparation of High-Purity Fucoxanthinol by SpyTag-Tailored Active Cholesterol Esterase Aggregates.
Jin W; Yang T; Chen H; Fang H; Chen W; Xie Q; Liu Q; Zhang Y; Hong Z; Zhang G
Mar Drugs; 2022 Nov; 20(11):. PubMed ID: 36421987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
